Trial
NCT04430959
Candesartan as an Adjunctive Treatment for Bipolar Depression
Early Phase IWITHDRAWNOPERATIONALConfidence: HIGH
Sponsor
The University of Texas Health Science Center, Houston
Collaborators
—
Condition
Bipolar Disorder Depression
Intervention
Candesartan
Why stopped
The reason the study was withdrawn was due to lack of funds. In addition, the PI is moving to a different institution and it would not be feasible to proceed with the study under these circumstances.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2022-04-27